why does nobody talk about semaglutide
why does nobody talk about semaglutide, and I want the answer with the reasoning attached rather than just the conclusion. The mental model that finally made this click for me: there are two curves, and people watch the wrong one. The first is exposure, which is set by the dose and smoothed by a week-long half-life.…
STEP-1 ran 68 weeks and landed just under 15% mean body weight change on 2.4mg. It is an average of a wide distribution, not a target you have missed.
Cosigning. The appetite change and the scale change ran about three weeks apart for me too.
STEP-1 averaged just under 15% at 68 weeks, so a 10% year is not a failure
[removed by moderator]
Minor fix — the half-life is about a week, not about a day. The rest of your point stands.
Disagree. 2.4 is the top of the label, not the goal, and "everyone ends up there" is just survivorship in the posts you read.
Research-use-only material is not approved for human use, so anything in this thread about how a compounded or research vial "should" behave is a chemistry discussion, not a dosing one.
My stall was eleven weeks. Eleven. Then it moved again without me changing anything at all.
reflux made the first fortnight rough at each step up, then flattened out. Predictable enough that I started planning around it.
Not convinced. You changed the dose and the week at the same time, so you cannot attribute the change to either.
I would push back gently. Going up because the scale paused is the single most common mistake described on this board.